New Target for Melanoma Treatment, Sanford-Burnham Medical Research Institute Study

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) today announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1 (PDK1), plays an essential role in the development and progression of melanoma. The finding offers a new approach to treating this life-threatening disease. The team of researchers, led by Ze’ev Ronai, Ph.D., professor and scientific director of Sanford-Burnham Medical Research Institute in La Jolla (San Diego, Calif.), used genetic mouse melanoma models to show the importance of the PDK1 gene in melanoma.

Hey, check out all the research scientist jobs. Post your resume today!